Established in Pusan
  President Y.O Kim inaugurated
  Distribution agreement with Merck
  Collaborated with Merrell Dow , USA
 

Collaborated with Parke-Davis , USA
Collaborated with Wyeth-Ayerst International Inc. , USA

  KGMP plant approved
  License agreement with Schering-Plough , USA
  R&D Center approved
 

License agreement with Lek d.d. Ljubljana , Slovenia
Launching Amocla TM (Broad spectrum antibiotics)

 

License agreement with Solco Basel AG , Switzerland
Launching Solcosplen (Treat for climacteric disorder)

 

Changing company's name to Kuhnil Pharmaceutical Co., Ltd.
Extending R&D center

 

License agreement with Biocodex , France
Launching Bioflor (Probiotics)

 

License agreement with Tedec Meiji , Spain

 

License agreement with Bausch&Lomb , USA
(Ophthalmic products including Ocuvite TM)
Established Penmix Ltd

  License agreement with King Pharmaceuticals , USA
 

License agreement with Novartis(Gerber) , Switzerland
License agreement with Lesvi and Vinas , Spain
License agreement with SMB and Ipr@d , France
License agreement with Senju(Bronuck) , Japan
License agreement with Pronova(Omacor) , Norway

 

License agreement with Biopro( Guilford) and Cubist , USA
License agreement with YM BioSciences , Canada
License agreement with Regulon , Greece
License agreement with Meforyl ER , USV India

 

Licence agreement with MEDOSAN and TTY Biotech.

 

Licence agreement whith EMCURE

 

Completed a subsidiary, STH Pharm
Investment Promotion to TTY, Taiwan

 

Kuhnil Pharmaceutical's headquarters moved to Jeong-dong, Jung-gu

 

R&D Center moved into Seoul Head Office

 

Contract with Neurim, Israel